Waters Corporation (WAT)

NYSE: WAT · Real-Time Price · USD
357.77
+13.06 (3.79%)
Nov 20, 2024, 4:00 PM EST - Market closed
3.79%
Market Cap 21.24B
Revenue (ttm) 2.91B
Net Income (ttm) 622.64M
Shares Out 59.38M
EPS (ttm) 10.48
PE Ratio 34.15
Forward PE 28.30
Dividend n/a
Ex-Dividend Date n/a
Volume 686,784
Open 343.39
Previous Close 344.71
Day's Range 340.62 - 358.04
52-Week Range 273.60 - 393.38
Beta 0.97
Analysts Hold
Price Target 363.92 (+1.72%)
Earnings Date Nov 1, 2024

About WAT

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies... [Read more]

Sector Healthcare
IPO Date Nov 16, 1995
Employees 7,900
Stock Exchange NYSE
Ticker Symbol WAT
Full Company Profile

Financial Performance

In 2023, Waters's revenue was $2.96 billion, a decrease of -0.52% compared to the previous year's $2.97 billion. Earnings were $642.23 million, a decrease of -9.26%.

Financial Statements

Analyst Forecast

According to 13 analysts, the average rating for WAT stock is "Hold." The 12-month stock price forecast is $363.92, which is an increase of 1.72% from the latest price.

Price Target
$363.92
(1.72% upside)
Analyst Consensus: Hold
Stock Forecasts

News

Waters Corporation to Present at the Evercore 2024 HealthCONx Conference

MILFORD, Mass. , Nov. 20, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D.

16 hours ago - PRNewsWire

Waters Corporation Opens State-of-the-Art Precision Manufacturing Facility in Longbridge, UK

News summary: Newly built 45,000 sq ft facility houses engineering and skilled manufacturing employees at Longbridge Business Park, a specialized hub for science and technology. Waters triples manufac...

7 days ago - PRNewsWire

Waters New Software Delivers Lab-Centric Business Intelligence and Enables Confident Audit-Readiness

News Summary: waters_connect™ Data Intelligence software provides laboratories with comprehensive business intelligence on their chromatographic data throughout the product development lifecycle, enab...

13 days ago - PRNewsWire

Waters Stock Leads S&P 500 Gains Friday as Earnings Top Estimates

Shares of Waters Corp. (WAT) surged nearly 20% on Friday, delivering the top daily performance in the S&P 500 after the company reported third-quarter sales and earnings that topped analysts' projecti...

19 days ago - Investopedia

S&P 500 Gains and Losses Today: Waters Stock Surges as Sales Improve

Following a pair of negative trading sessions, major U.S. equities indexes closed out the week on a strong note, pushing higher on Friday as investors cheered upbeat earnings results from e-commerce a...

19 days ago - Investopedia

Waters Corporation (WAT) Q3 2024 Earnings Call Transcript

Waters Corporation (NYSE:WAT) Q3 2024 Earnings Conference Call November 1, 2024 8:00 AM ET Company Participants Caspar Tudor – Head of Investor Relations Udit Batra – President and Chief Executive Of...

19 days ago - Seeking Alpha

Waters Corp raises annual profit forecast on higher demand for lab equipment

Waters Corp raised its annual profit forecast after beating Wall Street estimates for third-quarter profit and revenue on Friday, on improved demand for its products and services used in drug developm...

20 days ago - Reuters

Waters Corporation (NYSE: WAT) Reports Third Quarter 2024 Financial Results

Highlights Sales of $740 million exceeded guidance, grew 4% as reported and 4% in constant currency Instruments returned to growth; recurring revenue grew high single-digits in constant currency All r...

20 days ago - PRNewsWire

Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis

News Summary: Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and inn...

5 weeks ago - PRNewsWire

New Waters Discovery Core Rheometer Brings the Power of Rheology to Routine Quality Control Testing

News Summary: Easy-to-use, compact analyzer makes rheological insights more accessible to quality testing laboratories and material production facilities in batteries, pharmaceuticals, food, consumer ...

6 weeks ago - PRNewsWire

Waters Corporation Schedules Third Quarter 2024 Earnings Conference Call

MILFORD, Mass. , Oct. 7, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q3 2024 financial results conference call live on Friday, November 1st, 2024 at 8:00 a.m.

6 weeks ago - PRNewsWire

Waters Corp.: Embedded Expectations High Under Present Conditions

Waters continues to present with high-quality business characteristics, including high returns on capital employed and loads of freely available cash. Embedded expectations remain exquisitely high, ca...

3 months ago - Seeking Alpha

Waters Corporation Appoints Heather Knight to Board of Directors

MILFORD, Mass. , Aug. 14, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced the appointment of Heather Knight to its Board of Directors effective August 14, 2024.

3 months ago - PRNewsWire

These Analysts Revise Their Forecasts On Waters After Q2 Results

Waters Corporation WAT reported upbeat second-quarter earnings, but lowered its FY24 outlook on Wednesday.

3 months ago - Benzinga

Waters Corporation (WAT) Q2 2024 Earnings Call Transcript

Waters Corporation (NYSE:WAT) Q2 2024 Earnings Conference Call July 31, 2024 8:00 AM ET Company Participants Caspar Tudor - Head of Investor Relations Udit Batra - President and Chief Executive Offic...

4 months ago - Seeking Alpha

Waters Corporation (NYSE: WAT) Reports Second Quarter 2024 Financial Results

Highlights Sales of $709 million exceeded guidance on a reported basis, declined 4% as reported and 4% in organic constant currency GAAP EPS of $2.40; earnings exceeded guidance with non-GAAP EPS of $...

4 months ago - PRNewsWire

Waters New Rapid Screening-DSC Enables Up to 24x Faster Thermal Stability Testing at Ultra-Low Sample Volumes for Antibody Drugs

News Summary: Reduces sample volume requirements by 25x through use of advanced microfluidic technologies while increasing throughput up to 24x compared with competitor capillary DSC technologiesi. St...

4 months ago - PRNewsWire

Waters Corporation Schedules Second Quarter 2024 Earnings Conference Call

MILFORD, Mass. , July 2, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q2 2024 financial results conference call live on Wednesday, July 31st, 2024 at 8:00 a.m.

5 months ago - PRNewsWire

Waters Sets New Standards for High Resolution Performance and Speed with Xevo MRT Mass Spectrometer

News Summary: Waters Xevo™ MRT Mass Spectrometer employs next-generation multi-reflecting time-of-flight technology to deliver class-leading combination of high resolution and speed without compromisi...

6 months ago - PRNewsWire

Waters Becomes First Liquid Chromatography Column Provider to Receive My Green Lab ACT Ecolabel Certification

News Summary: Waters becomes the first vendor to obtain ACT™ Ecolabel Certification for 42 of its liquid chromatography columns, providing independent validation of the environmental impact of Waters ...

6 months ago - PRNewsWire

Waters Corporation to Present at the Jefferies 2024 Healthcare Conference

MILFORD, Mass. , May 13, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D.

6 months ago - PRNewsWire

Waters ACQUITY QDa II Mass Detector Delivers Wider Range of Chemical Analysis within Cost-Effective, Lower Energy Instrument

News Summary: ACQUITY™ QDa™ II Mass Detector enhances confidence in routine compound identification using the specificity of mass analysis to boost efficiency, robustness, and productivity in LC-UV se...

7 months ago - PRNewsWire

Waters Corporation (WAT) Q1 2024 Earnings Call Transcript

Waters Corporation (NYSE:WAT) Q1 2024 Earnings Conference Call May 7, 2024 8:30 AM ET Company Participants Caspar Tudor - Director, IR Udit Batra - President, CEO & Director Amol Chaubal - SVP & CFO ...

7 months ago - Seeking Alpha

Waters Corporation (NYSE: WAT) Reports First Quarter 2024 Financial Results

Highlights Sales of $637 million at the high-end of guidance, declined 7% as reported and 9% in organic constant curren cy GAAP EPS of $1.72; earnings well above guidance, with non-GAAP EPS of $2.21 O...

7 months ago - PRNewsWire

Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns

News Summary: New line of GTxResolve™ Premier SEC Columns provide higher sensitivity, resolution, and throughput to accelerate the development of cell & gene-based therapeutics. Reduces problematic no...

7 months ago - PRNewsWire